Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adocia SA (ADOIF)
OTHER OTC:ADOIF
Adocia SA (ADOIF) Stock Price & Analysis
7 Followers
ADOIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$8.87
Volume0.00
Average Volume (3M)N/A
Market Cap
$111.02M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.64Price Target Upside42.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ADOIF FAQ
What was Adocia SA’s price range in the past 12 months?
Currently, no data Available
What is Adocia SA’s market cap?
Currently, no data Available
When is Adocia SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adocia SA’s earnings last quarter?
Currently, no data Available
Is Adocia SA overvalued?
According to Wall Street analysts Adocia SA’s price is currently Undervalued.
Does Adocia SA pay dividends?
Adocia SA does not currently pay dividends.
What is Adocia SA’s EPS estimate?
Adocia SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adocia SA have?
Currently, no data Available
What happened to Adocia SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adocia SA?
Currently, no hedge funds are holding shares in ADOIF
---
Adocia SA Stock Smart Score
Company Description
Adocia SA
Adocia SA operates as a clinical-stage biotechnology company, which engages in the development of medicines from already approved therapeutic agents. Its product pipeline includes BioChaperone PDGF, which is in Phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone insulin that is in Phase I/II clinical trials, as well as in pre-clinical staged for the treatment of diabetes; and Driveln, which is in preclinical stage for the treatment of oncology, The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.
---
ADOIF Stock 12 Months Forecast
Average Price Target
$12.64
▲(42.49% Upside)
Technical Analysis
Best Analysts Covering ADOIF
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-15.00%
reiterated a buy rating a year ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -15.00% per trade.
---